James M Isbell Selected Research

James M Isbell Research Topics

24	Neoplasms (Cancer) 05/2024 - 08/2014
16	Lung Neoplasms (Lung Cancer) 05/2024 - 03/2014
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 02/2014
6	Esophageal Neoplasms (Esophageal Cancer) 11/2023 - 07/2013
6	Adenocarcinoma 01/2023 - 10/2014
5	Adenocarcinoma of Lung 01/2022 - 12/2019
4	Residual Neoplasm 11/2023 - 12/2017
3	Neoplasm Metastasis (Metastasis) 08/2022 - 07/2021
3	Inflammation (Inflammations) 01/2022 - 03/2015
3	Insulin Resistance 04/2013 - 07/2010
2	Pathologic Complete Response 02/2024 - 07/2013
2	Pain (Aches) 01/2021 - 01/2018
2	Weight Loss (Weight Reduction) 01/2016 - 07/2010
2	Wounds and Injuries (Trauma) 03/2015 - 09/2008
1	Margins of Excision 11/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023
1	Frailty 01/2023
1	Leukemia 01/2023
1	Atrial Fibrillation 01/2022
1	Myocardial Infarction 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Pericardial Effusion 02/2021
1	Pneumothorax 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Brain Neoplasms (Brain Tumor) 12/2019
1	Microsatellite Instability 12/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Esophageal Squamous Cell Carcinoma 01/2018
1	Anemia 01/2018
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2018
1	Death (Near-Death Experience) 11/2017
1	Hypoglycemia (Reactive Hypoglycemia) 02/2017
1	Deglutition Disorders (Dysphagia) 09/2016
1	Malnutrition (Nutritional Deficiencies) 09/2016
1	Cardiogenic Shock 10/2015
1	Diabetes Mellitus 10/2015
1	Urinary Tract Infections (Urinary Tract Infection) 10/2015

8	Circulating Tumor DNAIBA 11/2022 - 01/2017
5	Glucose (Dextrose)FDA LinkGeneric 02/2017 - 07/2010
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2018
3	Cell-Free Nucleic AcidsIBA 08/2022 - 12/2019
2	Carbon MonoxideIBA 01/2022 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2019
2	Opioid Analgesics (Opioids)IBA 01/2021 - 01/2018
2	IncretinsIBA 05/2011 - 07/2010
1	NucleotidesIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	ProstaglandinsIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2022
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2022
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2022
1	ChromatinIBA 01/2022
1	Anesthetics (Anesthetic Agents)IBA 02/2021
1	Ketamine FDA LinkGeneric 01/2021
1	KetorolacIBA 01/2021
1	Opioid Receptors (Opioid Receptor)IBA 01/2021
1	Polymethyl Methacrylate (Sol)IBA 12/2020
1	trastuzumab deruxtecanIBA 01/2020
1	Ado-Trastuzumab EmtansineIBA 01/2020
1	Cytotoxins (Cytolysins)IBA 01/2020
1	Immunoconjugates (Immunoconjugate)IBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 12/2019
1	human ERBB2 proteinIBA 12/2019
1	ORALIT (ORS)IBA 12/2019
1	NivolumabIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019

18	Therapeutics 01/2023 - 07/2013
9	Esophagectomy 11/2023 - 07/2013
8	Neoadjuvant Therapy 12/2023 - 09/2016
3	Radiotherapy 01/2023 - 02/2014
3	Length of Stay 12/2019 - 10/2015
3	Chemoradiotherapy 01/2018 - 07/2013
3	Gastric Bypass (Roux-en-Y Gastric Bypass) 05/2011 - 02/2010
2	Immunotherapy 02/2024 - 01/2018
2	Adjuvant Chemotherapy 01/2022 - 08/2021
2	Pneumonectomy (Lung Volume Reduction) 01/2022 - 07/2020
2	Thoracotomy 12/2019 - 01/2019
2	Blood Transfusion (Blood Transfusions) 01/2019 - 01/2018
2	Precision Medicine 12/2017 - 01/2017
2	Caloric Restriction 01/2016 - 07/2010
1	Electronic Nose 05/2024
1	Drug Therapy (Chemotherapy) 02/2024
1	Induction Chemotherapy 01/2023
1	Continuity of Patient Care 08/2022
1	Lymph Node Excision (Lymph Node Dissection) 01/2022
1	Thoracostomy 01/2021
1	Resuscitation 01/2020
1	Minimally Invasive Surgical Procedures 12/2019
1	Warm Ischemia 11/2017
1	Enteral Nutrition (Feeding, Tube) 09/2016
1	Catheters 10/2015
1	Cardiac Surgical Procedures 10/2015